Clinical trial · Interventional
Care Planning Framework in Advanced Cancer (ABC123)
Feasibility and Acceptability of the ABC123 Framework for Advanced Cancer Care
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Pilot study assessing the feasibility and acceptability of the ABC123 framework, as well as goal concordance between patient and clinician stated goals. Patients \>60 years old with recently diagnosed advanced, incurable cancer in for a first consultation at a participating medical oncology clinic. The team will pilot test the ABC123 framework delivery by an advanced practice provider working with a medical oncologist to inform the overall care planning process. This framework will routinely incorporate and implement existing resources from these 3 transdisciplinary tenets (geriatric, oncology, and palliative medicine) into initial care planning in a patient-centered manner. The team will follow patients from initial care planning to 6 months post-intervention and assess additional stakeholder feedback on barriers and facilitators to implementation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ABC123 Framework | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Older patients with advanced cancer
- description
- Patients over 60 years old with advanced, incurable cancer.
- interventionNames
- Behavioral: ABC123 Framework
Primary outcomes (3)
- measure
- Feasibility measured through recruitment
- timeFrame
- 3 years
- description
- Recruitment (proportion of those approached who actually enroll)
- measure
- Feasibility measured through retention in sessions
- timeFrame
- baseline to visit 2
- description
- Retention number of those completing both clinic sessions
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: 1. Provision to sign and date the consent form 2. Age \>65 years old, or \>60 with at least one deficit on a geriatric screen. 3. Stated willingness to comply with all study procedures and be available for the duration of the study 4. Diagnosis of a solid-tumor cancer that is not curable with surgery or radiation within the 6 mos. prior to consenting. And that would potentially be treated with systemic cytotoxic chemotherapy. If molecular marker status is pending for a particular tumor, patients may still be approached for enrollment in the study. 5. New patient consultation within the UCHealth Denver Metro system or newly diagnosed with recurrent metastatic/incurable disease 6. English speaking only for the pilot portion Exclusion Criteria: 1. Have a diagnosis of a different advanced cancer that has required systemic therapy 2. Have any condition that, in the opinion of the investigator, would compromise the well-being of the subject or the study or prevent the subject from meeting or performing study requirements
References
Publications (1)
- DERIVEDKessler ER, Min SJ, Hoover K, Coats H, Fischer SM. Feasibility and Acceptability of the ABC123 Framework for Advanced Cancer Care: Study Protocol. Nurs Res. 2026 May-Jun 01;75(3):241-245. doi: 10.1097/NNR.0000000000000888. Epub 2026 Feb 3. PMID 41630360